Sigma Advanced System Ltd
SIGMAADVSigma Advanced System Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: profits are rising, but only −69% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (61 weeks in) while the P/E sits at the 43rd percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +1,322.2% year on year, and −69% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Sigma Advanced System Ltd trades at ₹624, in a confirmed uptrend and 61 weeks into that stage. That is +98.6% against its own 200-day average. It sits at 100% of a 52-week range of ₹146 to ₹624. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 22 straight weeks.
Today the stock is in a confirmed uptrend — week 61 of stage 2, confirmed. At ₹624 it trades +98.6% versus its 200-day average and sits at 100% of its 52-week range (₹146–₹624).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +10,680% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 22 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Sigma Advanced System Ltd trades at 42.6× P/E, mid-range by its own standards (43rd percentile). Its long-run median P/E is 49.2×, measured across 10.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 42.6× is mid-range by its own standards (43rd percentile), against a long-run median of 49.2× measured over 10.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The price move, decomposed: over 5y, of the +110.5%/yr price move, ~+129.0%/yr came from earnings growth and ~−18.5 pp from the multiple (compressing); over 10y, of the +47.8%/yr price move, ~+57.3%/yr came from earnings growth and ~−9.5 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Sigma Advanced System Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 7 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | — | +526.6% | +52.8% | +22.8% |
| Profit | — | +210.0% | +166.3% | +74.9% |
| EPS | — | +133.2% | +127.4% | +55.8% |
| Share price | +439.0% | +153.0% | +110.5% | +47.8% |
4-Factor Sector Score
72.6/100 — rank 1 of 24 in Aerospace & Defence - Equipments · 93% evidence confidence
Sigma Advanced System Ltd scores 72.6 out of 100 against the 24 companies it is compared with in Aerospace & Defence - Equipments, ranking 1. Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
The four contributions add to the total exactly: 24 + 16.6 + 12 + 20 = 72.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Sigma Advanced System Ltd reported ₹323 Cr of revenue in the Mar 26 quarter, +466.7% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 22.8% a year. The last full year, FY26, came in at ₹492 Cr. The last four reported quarters add to ₹487 Cr.
FY26 revenue came in at ₹492 Cr (null on the year), capping 10 years at 22.8% compound. The latest quarter (Mar 26) printed ₹323 Cr, +466.7% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +567.5% growth against the decade's 22.8% — the current year is running faster than its own long-run rate.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Sigma Advanced System Ltd's operating margin is 17.0% in the Mar 26 quarter, −12.0 percentage points against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged −898.0% to 25.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 17.0%, −12.0 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged −898.0%–25.0%.
Why the margin moved: operating margin went +19.3 pp year on year while gross margin went +35.1 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Sigma Advanced System Ltd earned ₹128 Cr of net profit in the Mar 26 quarter, +1,322.2% year on year. Full-year FY26 profit was ₹268 Cr. The 10-year compound rate is 74.9%. That is 39.6% of the quarter's revenue. The same quarter a year earlier earned ₹9.0 Cr. 6 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹128 Cr, +1,322.2% year on year. On the full year, FY26 printed ₹268 Cr (null), and the 10-year compound rate is 74.9%.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −69% of Sigma Advanced System Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−225 Cr of operating cash against ₹268 Cr of profit. After ₹148 Cr of capital spending, ₹−373 Cr was left as free cash.
FY26: operating cash of ₹−225 Cr against reported profit of ₹268 Cr, leaving free cash of ₹−373 Cr after ₹148 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −69% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −69%: the cash cycle tightened 74 days between FY19 and FY26 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: the bigger cash user is investment — capital spending ran 8.4× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Sigma Advanced System Ltd's cash conversion cycle runs 271 days in FY26, down from 345 days in FY19. Capital spending ran ₹176 Cr over the last 3 years. At FY26 sales of ₹492 Cr each day of that cycle holds about ₹1.3 Cr, so roughly ₹365 Cr sits inside the business at any moment.
FY26: debtors at 270 days, inventory at 382 days — roughly 12.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 271 days, tighter than FY19's 345.
The full loop: cash goes out to suppliers and production on day 0; stock waits 382 days to sell; customers pay about 270 days after that; and suppliers themselves are paid at 381 days — netting out to the 271-day cycle.
In money terms: at FY26 sales of ₹492 Cr, each day of the cycle holds about ₹1.3 Cr — so the 271-day loop keeps roughly ₹365 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹176 Cr over the last 3 fiscal years against ₹21.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹9.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Sigma Advanced System Ltd earns a ROCE of 61% in FY26. That is up from a trough of 0% in FY17. Return on invested capital clears the cost of that capital by −4.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 54.5% net margin on 0.46× asset turns.
FY26 ROCE is 61%, recovered from a FY17 trough of 0% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 54.5% net margin × 0.46× asset turns × 2.26× balance-sheet leverage ≈ 56.7% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 7.3% − 12.0% = a −4.7 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Sigma Advanced System Ltd carries total debt of ₹332 Cr against shareholder equity of ₹468 Cr as of Mar 26, a debt-to-equity of 0.71. On the annual view that ratio went from 0.16 in FY22 to 0.71 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹332 Cr against shareholder equity of ₹468 Cr — a debt-to-equity of 0.71. On the annual view, debt-to-equity went from 0.16 (FY22) to 0.71 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 31.2 points of Sigma Advanced System Ltd over 8 quarters, the biggest move on the register. That takes promoters to 66.2% of the company. Foreign institutions moved +0.0 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +31.2 points over 8 quarters to 66.2%; Foreign institutions: +0.0 points over 8 quarters to 0.1%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.
Why the register moved: promoters drove it (+31.2 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Sigma Advanced System Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sigma Advanced System Ltdthis pageSIGMAADV | 72.6/100Favorable setup93% evidence | LEADER | 24.0/35 Revenue 100% · PAT 100% · OPM change -12 pp 83% evidence | 16.6/25 ROCE 60.8% · OPM 17% 95% evidence | 12.0/20 P/E 42.6× · PEG 2.35 100% evidence | 20.0/20 RS sector 105.2% · RS bench 142.5% · 1Y 494.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 16.6 + 12 + 20 = 72.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Sika Interplant Systems LtdSIKA | 72.6/100Favorable setup90% evidence | TURNING | 28.4/35 Revenue 43% · PAT 38.1% · OPM change 7.9 pp 88% evidence | 21.9/25 ROCE 34.6% · OPM 25.2% 100% evidence | 12.9/20 P/E 67.4× · PEG 1.01 100% evidence | 9.4/20 RS sector -10.2% · RS bench 6% · 1Y -1.7%3 of 7 weeks ahead 70% evidence |
| Exact sum: 28.4 + 21.9 + 12.9 + 9.4 = 72.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Astra Microwave Products LtdASTRAMICRO | 70.5/100Favorable setup96% evidence | LEADER | 21.0/35 Revenue 10.6% · PAT 27% · OPM change 4 pp 88% evidence | 19.4/25 ROCE 20.2% · OPM 33% 100% evidence | 10.8/20 P/E 91.6× · PEG 1.19 100% evidence | 19.3/20 RS sector 30.4% · RS bench 61.4% · 1Y 90.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 19.4 + 10.8 + 19.3 = 70.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Paras Defence and Space Technologies LtdPARAS | 66.4/100Favorable setup78% evidence | LEADER | 21.8/35 Revenue 30.4% · PAT 43.5% · OPM change -1 pp 83% evidence | 16.8/25 ROCE 16.9% · OPM 25% 76% evidence | 9.2/20 P/E 118× · PEG — 50% evidence | 18.6/20 RS sector 27.1% · RS bench 57.1% · 1Y 60.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 16.8 + 9.2 + 18.6 = 66.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5MTAR Technologies LtdMTARTECH | 63.2/100Mixed-positive evidence90% evidence | FADING | 30.7/35 Revenue 53.5% · PAT 100% · OPM change 6 pp 100% evidence | 13.9/25 ROCE 15.1% · OPM 24% 100% evidence | 6.3/20 P/E 129× · PEG — 50% evidence | 12.3/20 RS sector 21.9% · RS bench 44.7% · 1Y 280.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 30.7 + 13.9 + 6.3 + 12.3 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Apollo Micro Systems LtdAPOLLO | 59.9/100Mixed-positive evidence96% evidence | LEADER | 21.9/35 Revenue 60.9% · PAT 92.9% · OPM change 1 pp 88% evidence | 14.2/25 ROCE 14.5% · OPM 23% 100% evidence | 7.1/20 P/E 128× · PEG 1.6 100% evidence | 16.7/20 RS sector 6.5% · RS bench 32% · 1Y 126.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 14.2 + 7.1 + 16.7 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Vinyas Innovative Technologies LtdVINYAS | 59.3/100Thin evidence · provisional57% evidence | TURNING | 21.7/35 Revenue 65% · PAT 100% · OPM change 3 pp 48% evidence | 18.5/25 ROCE 21.4% · OPM 13% 95% evidence | 10.9/20 P/E 51.1× · PEG — 15% evidence | 8.2/20 RS sector -17.5% · RS bench 6% · 1Y -6.9%10 of 11 weeks ahead 70% evidence |
| Exact sum: 21.7 + 18.5 + 10.9 + 8.2 = 59.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Data Patterns (India) LtdDATAPATTNS | 58.1/100Mixed-positive evidence100% evidence | FADING | 21.5/35 Revenue 33.9% · PAT 24.2% · OPM change -5 pp 100% evidence | 18.6/25 ROCE 21.9% · OPM 27% 100% evidence | 5.0/20 P/E 88.7× · PEG 3.94 100% evidence | 13.0/20 RS sector 5% · RS bench 30.1% · 1Y 59.9%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 18.6 + 5 + 13 = 58.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 9Azad Engineering LtdAZAD | 57.4/100Mixed-positive evidence89% evidence | FADING | 24.5/35 Revenue 32.2% · PAT 54% · OPM change 2 pp 88% evidence | 12.9/25 ROCE 11.9% · OPM 38% 100% evidence | 8.0/20 P/E 111× · PEG 2.29 65% evidence | 12.0/20 RS sector 1.6% · RS bench 27% · 1Y 47.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 12.9 + 8 + 12 = 57.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Ideaforge Technology LtdIDEAFORGE | 57.1/100Mixed-positive evidence68% evidence | LEADER | 24.6/35 Revenue 41% · PAT 71.4% · OPM change 152 pp 65% evidence | 4.6/25 ROCE -2.8% · OPM 44% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 17.9/20 RS sector 25.6% · RS bench 53.6% · 1Y 85.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 4.6 + 10 + 17.9 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Hindustan Aeronautics LtdHAL | 56.2/100Mixed-positive evidence96% evidence | BREAKING OUT | 11.0/35 Revenue 6.8% · PAT 9% · OPM change -3 pp 88% evidence | 21.1/25 ROCE 32% · OPM 36% 100% evidence | 15.2/20 P/E 34.1× · PEG 1.18 100% evidence | 8.9/20 RS sector -18.6% · RS bench 4% · 1Y 2.1%8 of 12 weeks ahead 100% evidence |
| Exact sum: 11 + 21.1 + 15.2 + 8.9 = 56.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Rossell Techsys LtdROSSTECH | 54.1/100Mixed-positive evidence83% evidence | FADING | 29.0/35 Revenue 82.9% · PAT 68.8% · OPM change 1.8 pp 100% evidence | 7.4/25 ROCE 11.5% · OPM 14.4% 100% evidence | 9.0/20 P/E 136× · PEG — 15% evidence | 8.7/20 RS sector -3.2% · RS bench 20.7% · 1Y 64.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 29 + 7.4 + 9 + 8.7 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Jaykay Enterprises LtdJAYKAY | 49.0/100Mixed-negative evidence62% evidence | ASLEEP | 25.8/35 Revenue 100% · PAT 100% · OPM change 34 pp 62% evidence | 6.8/25 ROCE 8.2% · OPM -10% 95% evidence | 11.5/20 P/E 32.6× · PEG — 15% evidence | 4.9/20 RS sector -20.9% · RS bench -6.2% · 1Y 20.6%6 of 10 weeks ahead 70% evidence |
| Exact sum: 25.8 + 6.8 + 11.5 + 4.9 = 49 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 20.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 14Mishra Dhatu Nigam LtdMIDHANI | 45.7/100Mixed-negative evidence96% evidence | FADING | 16.3/35 Revenue 12.6% · PAT 18.9% · OPM change -2 pp 88% evidence | 13.7/25 ROCE 11.3% · OPM 21% 100% evidence | 7.4/20 P/E 56.4× · PEG 5.62 100% evidence | 8.3/20 RS sector -16.9% · RS bench 5.1% · 1Y -2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.7 + 7.4 + 8.3 = 45.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Dynamatic Technologies LtdDYNAMATECH | 43.8/100Mixed-negative evidence89% evidence | FADING | 16.2/35 Revenue 15.5% · PAT -23.3% · OPM change 1 pp 88% evidence | 10.2/25 ROCE 10% · OPM 11% 100% evidence | 10.3/20 P/E 140× · PEG 1.42 65% evidence | 7.1/20 RS sector -12.3% · RS bench 10.4% · 1Y 47.5%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 10.2 + 10.3 + 7.1 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Zen Technologies LtdZENTEC | 41.9/100Mixed-negative evidence69% evidence | ASLEEP | 5.0/35 Revenue -23.4% · PAT -27.8% · OPM change -14 pp 95% evidence | 16.6/25 ROCE 16.2% · OPM 27% 76% evidence | 10.5/20 P/E 80.7× · PEG — 15% evidence | 9.8/20 RS sector -6.5% · RS bench 6.5% · 1Y -8.7%8 of 10 weeks ahead 70% evidence |
| Exact sum: 5 + 16.6 + 10.5 + 9.8 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Bharat Electronics LtdBEL | 41.7/100Mixed-negative evidence100% evidence | ASLEEP | 14.0/35 Revenue 19.8% · PAT 11.8% · OPM change -3 pp 100% evidence | 18.6/25 ROCE 36.5% · OPM 25% 100% evidence | 7.3/20 P/E 46.1× · PEG 3.54 100% evidence | 1.8/20 RS sector -28% · RS bench -8% · 1Y -1.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14 + 18.6 + 7.3 + 1.8 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Aequs LtdAEQUS | 36.4/100Thin evidence · provisional51% evidence | BREAKING OUT | 15.1/35 Revenue 44.3% · PAT — · OPM change -7.3 pp 74% evidence | 1.3/25 ROCE 1.6% · OPM 3.7% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 15.1 + 1.3 + 10 + 10 = 36.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Avantel LtdAVANTEL | 35.7/100Mixed-negative evidence77% evidence | TURNING | 10.1/35 Revenue -3.2% · PAT -67.2% · OPM change 4.6 pp 100% evidence | 9.2/25 ROCE 9.6% · OPM 24.8% 100% evidence | 8.7/20 P/E 251× · PEG — 15% evidence | 7.7/20 RS sector -11.9% · RS bench 0.1% · 1Y 19%8 of 11 weeks ahead 70% evidence |
| Exact sum: 10.1 + 9.2 + 8.7 + 7.7 = 35.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20AXISCADES Technologies LtdAXISCADES | 35.4/100Mixed-negative evidence96% evidence | ASLEEP | 15.4/35 Revenue 12.4% · PAT -4.3% · OPM change -1.7 pp 88% evidence | 12.3/25 ROCE 15.3% · OPM 12.3% 100% evidence | 4.9/20 P/E 83.6× · PEG 3.04 100% evidence | 2.8/20 RS sector -21.3% · RS bench -1.3% · 1Y 13.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 12.3 + 4.9 + 2.8 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21NIBE LtdNIBE | 32.4/100Adverse evidence65% evidence | TURNING | 9.6/35 Revenue -6.7% · PAT -80% · OPM change 3 pp 83% evidence | 7.6/25 ROCE 4.8% · OPM 20% 76% evidence | 8.5/20 P/E 380× · PEG — 15% evidence | 6.7/20 RS sector -29.8% · RS bench 11.1% · 1Y -17%11 of 11 weeks ahead 70% evidence |
| Exact sum: 9.6 + 7.6 + 8.5 + 6.7 = 32.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Bharat Dynamics LtdBDL | 29.4/100Adverse evidence83% evidence | ASLEEP | 7.6/35 Revenue -27% · PAT -23.6% · OPM change -5 pp 88% evidence | 12.9/25 ROCE 13.8% · OPM 12% 100% evidence | 5.0/20 P/E 109× · PEG 4.44 65% evidence | 3.9/20 RS sector -22.4% · RS bench -11.8% · 1Y -24.4%2 of 10 weeks ahead 70% evidence |
| Exact sum: 7.6 + 12.9 + 5 + 3.9 = 29.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23BEML LtdBEML | 26.3/100Adverse evidence90% evidence | ASLEEP | 6.5/35 Revenue 8.1% · PAT -51.5% · OPM change -11 pp 88% evidence | 5.3/25 ROCE 7.7% · OPM 15% 100% evidence | 9.5/20 P/E 103× · PEG 1.18 100% evidence | 5.0/20 RS sector -19.9% · RS bench -6.2% · 1Y -15.6%5 of 10 weeks ahead 70% evidence |
| Exact sum: 6.5 + 5.3 + 9.5 + 5 = 26.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24DCX Systems LtdDCXINDIA | 25.1/100Adverse evidence67% evidence | ASLEEP | 8.2/35 Revenue -31.4% · PAT -80% · OPM change -2 pp 83% evidence | 3.4/25 ROCE 0.9% · OPM -0.2% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -27% · RS bench -12.4% · 1Y -32%5 of 10 weeks ahead 70% evidence |
| Exact sum: 8.2 + 3.4 + 10 + 3.5 = 25.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Sigma Advanced System Ltd's share price today?
Sigma Advanced System Ltd trades at ₹624, +439.0% over the past year. The company is valued at ₹11,816 Cr. The stock sits at 100% of its 52-week range of ₹146–₹624, +98.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 61 weeks in. — as of 31 July 2026.
What were Sigma Advanced System Ltd's latest quarterly results?
Sigma Advanced System Ltd reported revenue of ₹323 Cr and net profit of ₹128 Cr for the Mar 26 quarter. Revenue rose 466.7% and profit rose 1,322.2% year on year. Earnings per share were ₹7.29. The operating margin was 17.0%, 12.0 pp lower than a year earlier. — as of 31 July 2026.
What is Sigma Advanced System Ltd's revenue?
Sigma Advanced System Ltd reported revenue of ₹323 Cr in the Mar 26 quarter, +466.7% year on year. For the full FY26 fiscal year, revenue was ₹492 Cr. Over the last 10 years revenue compounded at 22.8% a year. — as of 31 July 2026.
What is Sigma Advanced System Ltd's profit?
Sigma Advanced System Ltd earned ₹128 Cr of net profit in the Mar 26 quarter, +1,322.2% year on year. Full-year FY26 profit was ₹268 Cr. The operating margin ran 17.0% in the latest quarter. — as of 31 July 2026.
What is Sigma Advanced System Ltd's market cap?
Sigma Advanced System Ltd's market capitalisation is ₹11,816 Cr at a share price of ₹624. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Sigma Advanced System Ltd's P/E ratio?
Sigma Advanced System Ltd trades at a P/E of 42.6×, at the 43rd percentile of its own 10-year range, against a long-run median of 49.2×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Sigma Advanced System Ltd pay a dividend?
No — Sigma Advanced System Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Sigma Advanced System Ltd overvalued?
On its own history, Sigma Advanced System Ltd looks mid-range against its own history: its P/E of 42.6× sits at the 43rd percentile of its 10-year range (long-run median 49.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Sigma Advanced System Ltd growing?
Yes — Sigma Advanced System Ltd is growing: latest-quarter revenue +466.7% year on year, profit +1,322.2%, and the margin −12.0 pp at 17.0%. The 10-year compound rates are 22.8% (revenue) and 74.9% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Sigma Advanced System Ltd performing?
Sigma Advanced System Ltd is in a confirmed uptrend, 61 weeks in. Its latest quarter's revenue rose 466.7% and profit rose 1,322.2% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 22 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Sigma Advanced System Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 61 of stage 2), trading +98.6% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Sigma Advanced System Ltd beating the market?
On recent form, yes — Sigma Advanced System Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 22 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +10,680% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Sigma Advanced System Ltd's share price go up?
This page publishes no price forecast for Sigma Advanced System Ltd. What it measures instead: the share price is ₹624, the price is in a confirmed uptrend 61 weeks in. Its P/E of 42.6× sits at the 43rd percentile of its own 10-year range. — as of 31 July 2026.
Who owns Sigma Advanced System Ltd?
Promoters hold 66.2% of Sigma Advanced System Ltd, foreign institutions 0.1%, domestic institutions 0.0% and the public 33.6% (latest quarter). The biggest move on the register over the last two years: Promoters added 31.2 points over 8 quarters. — as of 31 July 2026.
Does Sigma Advanced System Ltd have too much debt?
It is moderate — Sigma Advanced System Ltd's debt-to-equity is 0.71, and operating profit covers the interest bill 2×. FY26 borrowings were ₹332 Cr against equity of ₹468 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Sigma Advanced System Ltd's capex?
Sigma Advanced System Ltd spent ₹176 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹148 Cr, with ₹9.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Sigma Advanced System Ltd's cash flow?
Sigma Advanced System Ltd generated ₹−225 Cr of operating cash flow in FY26 and ₹−373 Cr of free cash flow after ₹148 Cr of capital spending. Reported profit that year was ₹268 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Sigma Advanced System Ltd's profit real cash?
Not fully — over the last 3 fiscal years, −69% of Sigma Advanced System Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−225 Cr against reported profit of ₹268 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Sigma Advanced System Ltd in its business cycle?
Sigma Advanced System Ltd's FY26 operating margin was 10.0%, against a 12-year band of −898.0%–25.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 17.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Sigma Advanced System Ltd story?
The sharpest disagreement: profits are rising, but only −69% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Sigma Advanced System Ltd a stock worth studying right now?
This is not investment advice. The machine read: Sigma Advanced System Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.